arrow
返回
N

Noah M. Hahn

johns hopkins university

58H指数
576论文数
1.8W被引数
收录论文 115
发表时间
UPDATED ANALYSIS OF COST-EFFECTIVENESS AMONG BLADDER-SPARING TREATMENTS FOR BCG-UNRESPONSIVE CIS: INCORPORATING RECENTLY APPROVED AND ESTABLISHED THERAPIES更新对BCG无应答性原位癌的保膀胱治疗方案的成本效益分析:纳入近期批准和已建立的疗法
err2026-05-01
err0
PREAI
errMyers, Amanda A.; Talwar, Ruchika; Duan, Zhigang; Hensley, Patrick; Lotan, Yair; Williams, Stephen B.; Luckenbaugh, Amy N.; Li, Roger; Kassouf, Wassim; Necchi, Andrea; Packiam, Vignesh T.; Shore, Neal D.; Steinberg, Gary D.; Witjes, J. Alfred; Schmidt, Bogdana; Porten, Sima; Hahn, Noah M.; Bree, Kelly K.; Toumazis, Iakovos; Zhao, Hui; Kamat, Ashish M.
err分享
err收藏
DETECTABLE TISSUE-INFORMED CIRCULATING TUMOR DNA IS ASSOCIATED WITH PROGRESSION IN PATIENTS TREATED SURGICALLY FOR UPPER TRACT UROTHELIAL CARCINOMA可检测的组织信息循环肿瘤DNA与接受手术治疗的上尿路尿路上皮癌患者进展相关
err2026-05-01
err0
PREAI
errArbuiso, Alyssa; Korn, Philipp; Cheaib, Joseph; Rivera-Lopez, Carlos; Vlachou, Evangelia; Patel, Sunil; Smith, Armine; Johnson III, Burles A.; Hahn, Noah; Kates, Max; Hoffman-Censits, Jeannie; Singla, Nirmish
err分享
err收藏
err分享
err收藏
Dynamics of Tumor-informed Circulating Tumor DNA and Association with Clinical Responses to Enfortumab and Pembrolizumab in Patients with Locally Advanced or Metastatic Urothelial Carcinoma肿瘤来源循环肿瘤DNA的动力学变化及其与局部晚期或转移性尿路上皮癌患者对恩诺单抗(Enfortumab)和帕博利珠单抗(Pembrolizumab)临床反应的相关性
err2025-12-05
err0
PREAI
errEvangelia Vlachou; Burles Avner Johnson; Max Kates; Nirmish Singla; Sunil Patel; Armine Smith; Stephanie Russell; Daniel Stairiker; Kelli Rourke; Bruce J. Trock; Alyssa Arbuiso; Andres Matoso; Ezra G. Baraban; David McConkey; Noah M. Hahn; Jean Hoffman-Censits
err分享
err收藏
Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin–unresponsive Carcinoma in Situ of the Bladder膀胱原位癌对卡介苗无反应的治疗方案的成本效益分析
err2025-10-04
err0
PREAI
errAmanda A. Myers; Ruchika Talwar; Zhigang Duan; Patrick Hensley; Yair Lotan; Stephen B. Williams; Amy N. Luckenbaugh; Roger Li; Wassim Kassouf; Andrea Necchi; Vignesh T. Packiam; Neal Shore; Gary D. Steinberg; J.Alfred Witjes; Bogdana Schmidt; Sima Porten; Noah M. Hahn; Kelly K. Bree; Iakovos Toumazis; Hui Zhao; Ashish M. Kamat
err分享
err收藏
Sarcomatoid areas of urothelial carcinoma are enriched for CD163-positive antigen-presenting cells
err2025-02-19
err0
errOAAI
errJohnson III, Burles A.; Parimi, Vamsi; Kamanda, Sonia; Corney, David C.; Choi, Woonyoung; Hoffman-Censits, Jean; Kates, Max; Mcconkey, David J.; Hahn, Noah M.; Matoso, Andres
err分享
err收藏
PrECOG PrE0807: A Phase 1b Feasibility Trial of Neoadjuvant Nivolumab Without and with Lirilumab in Patients with Muscle-invasive Bladder Cancer Ineligible for or Refusing Cisplatin-based Neoadjuvant Chemotherapy
err2024-08-01
err5
PREAI
errGrivas, Petros; Koshkin, Vadim S.; Chu, Xiangying; Cole, Suzanne; Jain, Rohit K.; Dreicer, Robert; Cetnar, Jeremy P.; Sundi, Debasish; Gartrell, Benjamin A.; Galsky, Matthew D.; Woo, Brianna; Li-Ning-Tapia, Elsa; Hahn, Noah M.; Carducci, Michael A.
err分享
err收藏
A Phase 2 Trial of Intravesical Gemcitabine and Docetaxel in the Treatment of Bacillus Calmette-Guérin-Naïve Nonmuscle-Invasive Urothelial Carcinoma of the Bladder Reply
err2024-07-01
err0
PREAI
errPatel, Sunil H.; Gabrielson, Andrew T.; Chan, Sin; Schwartz, Deborah; Collins, Connie; Singla, Nirmish; Trock, Bruce; Bivalacqua, Trinity J.; Hahn, Noah; Kates, Max R.
err分享
err收藏
A Phase 2 Trial of Intravesical Gemcitabine and Docetaxel in the Treatment of Bacillus Calmette-Guérin-Naïve Nonmuscle-Invasive Urothelial Carcinoma of the Bladder
err2024-07-01
err9
PREAI
errPatel, Sunil H.; Gabrielson, Andrew T.; Chan, Sin; Schwartz, Deborah; Collins, Connie; Singla, Nirmish; Trock, Bruce; Bivalacqua, Trinity J.; Hahn, Noah; Kates, Max R.
err分享
err收藏
Enfortumab vedotin-related cutaneous toxicity correlates with overall survival in patients with urothelial cancer: a retrospective experience
err2024-06-12
err6
errOAAI
errVlachou, Evangelia; Johnson III, Burles Avner; Mcconkey, David; Jing, Yuezhou; Matoso, Andres; Hahn, Noah M.; Hoffman-Censits, Jean
err分享
err收藏
A PHASE II TRIAL OF INTRAVESICAL GEMCITABINE AND DOCETAXEL (GEMDOCE) IN THE TREATMENT OF BCG-NA_IVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
err2024-05-01
err0
PREAI
errPatel, Sunil H.; Gabrielson, Andrew T.; Chan, Sin; Schwartz, Deborah; Collins, Connie; Singla, Nirmish; Trock, Bruce; Bivalacqua, Trinity J.; Hahn, Noah; Kates, Max R.
err分享
err收藏
Checkpoint Inhibitors in Urothelial Carcinoma-Future Directions and Biomarker Selection
err2023-11-01
err19
errOAAI
errMeeks, Joshua J.; Black, Peter C.; Galsky, Matthew; Grivas, Petros; Hahn, Noah M.; Hussain, Syed A.; Milowsky, Matthew I.; Steinberg, Gary D.; Svatek, Robert S.; Rosenberg, Jonathan E.
err分享
err收藏
The JAVELIN Bladder Medley trial: avelumab-based combinations as first-line maintenance in advanced urothelial carcinoma
err2023-09-06
err7
errOAAI
errHoffman-Censits, Jean; Grivas, Petros; Powles, Thomas; Hawley, Jessica; Tyroller, Karin; Seeberger, Sonja; Guenther, Silke; Jacob, Natalia; Mehr, Keyvan Tadjalli; Hahn, Noah M.
err分享
err收藏